Home › Compare › EMMRF vs JNJ

EMMRF vs JNJ: Dividend Comparison 2026

EMMRF yields 66666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMMRF wins by $8.441837856534449e+24M in total portfolio value
10 years
EMMRF
EMMRF
● Live price
66666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.441837856534449e+24M
Annual income
$8,417,001,582,403,749,000,000,000,000,000.00
Full EMMRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EMMRF vs JNJ

📍 EMMRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMMRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMMRF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMMRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMMRF
Annual income on $10K today (after 15% tax)
$5,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,154,451,345,043,187,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EMMRF beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMMRF + JNJ for your $10,000?

EMMRF: 50%JNJ: 50%
100% JNJ50/50100% EMMRF
Portfolio after 10yr
$4.2209189282672247e+24M
Annual income
$4,208,500,791,201,874,400,000,000,000,000.00/yr
Blended yield
99.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EMMRF
No analyst data
Altman Z
-7.0
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMMRF buys
0
JNJ buys
0
No recent congressional trades found for EMMRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMMRFJNJ
Forward yield66666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8.441837856534449e+24M$20.0K ✓
Annual income after 10y$8,417,001,582,403,749,000,000,000,000,000.00 ✓$827.78
Total dividends collected$8.44020886744369e+24M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMMRF vs JNJ ($10,000, DRIP)

YearEMMRF PortfolioEMMRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$6,677,367$6,666,666.67$10,676$355.77+$6.67M → EMMRF
2$4,167,497,846$4,160,353,063.34$11,407$389.39+$4167.49M → EMMRF
3$2,431,161,901,635$2,426,702,678,939.67$12,198$426.53+$2431161.89M → EMMRF
4$1,325,636,209,022,888$1,323,034,865,788,139.00$13,056$467.62+$1325636209.01M → EMMRF
5$675,632,775,263,916,700$674,214,344,520,262,300.00$13,987$513.12+$675632775263.90M → EMMRF
6$321,867,481,182,444,260,000$321,144,554,112,911,900,000.00$14,998$563.56+$321867481182444.25M → EMMRF
7$143,326,993,661,751,470,000,000$142,982,595,456,886,240,000,000.00$16,098$619.52+$143326993661751472.00M → EMMRF
8$59,657,925,421,851,500,000,000,000$59,504,565,538,633,426,000,000,000.00$17,295$681.69+$59657925421851500544.00M → EMMRF
9$23,211,471,150,187,795,000,000,000,000$23,147,637,169,986,416,000,000,000,000.00$18,599$750.82+$2.3211471150187796e+22M → EMMRF
10$8,441,837,856,534,450,000,000,000,000,000$8,417,001,582,403,749,000,000,000,000,000.00$20,022$827.78+$8.441837856534449e+24M → EMMRF

EMMRF vs JNJ: Complete Analysis 2026

EMMRF — Stock

Emmerson Resources Limited, together with its subsidiaries, engages in the exploration and evaluation of mineral properties. The company primarily explores for gold, copper, and cobalt deposits. It holds interest in the Tennant Creek Mineral Field covering an area of 1,700 square kilometers located in the Northern Territory, Australia. The company also holds interests in five projects located in New South Wales, Australia. Emmerson Resources Limited was incorporated in 2005 and is based in West Leederville, Australia.

Full EMMRF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EMMRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMMRF vs SCHDEMMRF vs JEPIEMMRF vs OEMMRF vs KOEMMRF vs MAINEMMRF vs ABBVEMMRF vs MRKEMMRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.